Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MILACLE study: IGMKK16E7 oral mucosal immunotherapy for HPV16-related HSIL/CIN2-3
jRCT2031190034Phase 2Completed
- Start
- May 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cervical intraepithelial neoplasia (CIN) (4 arms). Started May 2019; status: completed.
02
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on jRCT2031190034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031190034.